- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07655713
Postoperative Urinary Retention Management in the Post Anesthesia Care Unit (GEREMIS)
GEstion de la REprise MIctionnelle en Salle de Surveillance Post-interventionnelle/ Management of Postoperative Urinary Void Recovery in the Post-Anesthesia Care Unit
Introduction : The post-anesthesia care unit (PACU) admits patients in the immediate post-operative period in order to ensure monitoring, prevention, and management of early complications related to anesthesia and surgery. Post-operative urinary retention (POUR), inability to urinate despite a full bladder, is a common complication. Its incidence, causes, contributing factors, and complications have been the subject of numerous studies. Although well known, this complication has never had a consensus definition, particularly in terms of bladder volume, and the clinical signs known in urology are not always present post-operatively, notably pain and a feeling of fullness. In the event of POUR, bladder catheterization (intermittent catheterization, indwelling catheter placement, or suprapubic catheter) is often unavoidable, even though some studies have explored the possibility of pharmacological treatment. This procedure is invasive and carries its own risks: infection, trauma, bleeding, pain, discomfort, and loss of privacy/dignity. The challenge is to monitor and manage the onset of POUR while limiting unnecessary catheterization. For this purpose, bladder ultrasound is recommended to measure bladder volume. Previously performed by physicians using medical ultrasound machines, the arrival on the market of portable bladder scanners, which are non-invasive and simple to use, has made it possible to extend this examination to nurses. This diagnostic tool is a valuable aid in cases of suspected POUR (presence of clinical signs) or for patients at risk of obstruction. It helps guide medical decision-making regarding bladder catheterization. These devices, which have been available on the market for about thirty years, have gradually been adopted by care units, likely limited by the cost of investment. The PACUs of our institution have been equipped with this device for less than 7 years, with one of them having acquired it more recently, in 2025. Experienced staff members in the department have reported a sense that the use of the device varies among professionals, and that the number of intermittent catheterizations performed in the PACU has increased since the device was introduced. In this context, we wish to evaluate our practices regarding the management of post-operative urinary voiding recovery, the appropriateness of bladder scanner uses in the PACU, and the appropriateness of bladder catheterization decisions. This project will describe practices regarding the management of urinary voiding recovery, analyze the appropriateness of bladder catheterizations, and help understand the clinical reasoning of healthcare staff. It is part of paramedical research on the evolution of practices with decision-support technologies.
Methods: A nursing observational study on care practices, Single-center, mixed-methods study (prospective and retrospective), using data collected as part of routine care for the quantitative analysis and a practice survey by questionnaire addressed to healthcare staff for the qualitative analysis. Data will be collected as part of routine care from medical records (PACU monitoring sheet and electronic patient record) and from a study-specific data collection form for the prospective component, allowing further detail on the modalities of nursing care. Data will be collected over the period between admission to the PACU and the 24 hours following discharge from the PACU. The medical records of 970 patients will be analyzed (485 retrospectively and 485 prospectively). In addition, an anonymous questionnaire will be given to nursing staff working in the PACU, to explore current knowledge and practice habits.
Studienübersicht
Status
Studientyp
Einschreibung (Geschätzt)
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Patient admitted to the PACU for post-operative monitoring (excluding outpatient/ambulatory and endoscopy cases)
- Standard post-operative monitoring (transfer to a surgical ward after the monitoring period)
- Adult patient (≥18 years)
Exclusion Criteria:
- Post-operative care following urological surgery
- History of chronic urinary retention
- Presence of an indwelling urinary drainage system upon arrival in the PACU (urinary catheter, Bricker ileal conduit, suprapubic catheter)
- Chronic renal failure requiring dialysis
- Transfer to intensive care after the PACU monitoring period
- Patient under legal protection (guardianship/conservatorship)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Evaluate the incidence of potentially avoidable urinary catheterizations performed post-operatively in the PACU.
Zeitfenster: 24 hours
|
Proportion of catheterizations with an initial drained volume <500 mL among all urinary catheterizations performed in the PACU in included patients
|
24 hours
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Evaluate the appropriateness of bladder scanner use
Zeitfenster: 24 hours
|
Proportion of patients having had at least one bladder scan measurement in the PACU.
Description of urinary volumes measured by bladder scan (median/IQR).
Proportion of measurements associated with the presence of clinical signs of urinary retention, and proportion of measurements associated with the presence of factors contributing to retention
|
24 hours
|
|
Analyze post-operative urinary voiding recovery and its modalities
Zeitfenster: 24 hours
|
Proportion of patients with voiding recovery in the PACU, proportion of patients with voiding recovery upon return to the surgical ward, by modality of voiding recovery: voluntary or prompted by staff (prospective component).
|
24 hours
|
|
Measure the rate of intermittent catheterizations and the average volume drained
Zeitfenster: 24 hours
|
Proportion of patients who underwent intermittent catheterization in the PACU, proportion of patients who underwent intermittent catheterization upon return to the surgical ward, description of drained volumes (median/IQR).
|
24 hours
|
|
Evaluate the decision criteria for intermittent catheterization (prospective component)
Zeitfenster: 24 hours
|
Among catheterized patients: proportion of patients with presence/absence of clinical signs of POUR, proportion of patients with a prior bladder scan measurement, description of the median/IQR bladder scan volume
|
24 hours
|
|
Evaluate the correlation between the bladder catheterization rate and length of stay in the PACU (prospective component)
Zeitfenster: 24 hours
|
Median length of stay in the PACU among patients who required catheterization and among patients who did not require catheterization
|
24 hours
|
|
Analyze staff clinical reasoning (questionnaire)
Zeitfenster: 24 hours
|
Description of the decision criteria for catheterization, decision criteria for bladder scan use, and management of voiding.
|
24 hours
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- IRB 00010254 - 2026 - 084
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .